Take profits

Following a rise in the EQTEC share price to 2.635p, ahead of our target price of 1.39p, we move our stance to TAKE PROFITS.


EQTEC is a research client of Align Research.  Full details of our Company & Personal Account Dealing Policy can be found on our website http://www.alignresearch.co.uk/legal/ 

For full disclaimer information please refer to the last page of the full document. This investment may not be suitable for your personal circumstances. If you are in any doubt as to its suitability you should seek professional advice. This note does not constitute advice and your capital is at risk. This is a marketing communication and cannot be considered independent research.

Table: financial overview
Year to Dec 2020E 2021E 2022E
Revenues (€m) 6.96 38.49 65.99
Pre-tax (€) (0.93) 5.33 10.76
EPS (p) (0.0149) 0.0683 0.1103
Source: Align Research